Country: United Kingdom
Bahasa: Inggeris
Sumber: VMD (Veterinary Medicines Directorate)
Glucose, Sodium Chloride
Dechra Limited
QB05BB02
Glucose, Sodium Chloride
Solution for infusion
POM-V - Prescription Only Medicine – Veterinarian
Cats, Cattle, Dogs, Horses
Replacement Agent
Authorized
1998-12-09
Revised: June 2016 AN: 01534/2015 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetivex 18 (Sodium chloride 0.18 % w/v and Glucose 4 % w/v intravenous solution for infusion BP (Vet)) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: Sodium chloride 0.18 % w/v Glucose monohydrate 4.4 % w/v (equivalent to anhydrous glucose 4.0 % w/v) Approximate ionic content in millimoles per litre: Sodium 30 mmol/L Chloride 30 mmol/L Each one litre provides approximately 150 kcal. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Infusion Clear, colourless solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, calves, horses, dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES This product is administered by intravenous infusion for maintenance therapy of dehydration in cattle, calves, horses, dogs and cats. It should be used once the underlying fluid balance has been restored. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Revised: June 2016 AN: 01534/2015 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Sodium overload may occur in animals with cardiac or renal impairment. It should be noted that sodium excretion may be impaired post-surgery/trauma. Administration of this product to diabetic animals must be conducted with extreme caution. The solution should ideally be warmed to approximately 37 o C prior to the administration of large volumes, or if the administration rate is high, in order to avoid hypothermia. This product should not be used for prolonged periods of time unless there is continuing excessive loss of electrolytes, as it may provoke hypokalaemia. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS Not applicable. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) There is a risk of thrombosis with intravenous infusion. Excessive infusion rates can cause restlessness, moist lung sounds, tachycar Baca dokumen lengkap